TSX open
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/TSX-V/LSL

LSL Pharma Group Inc. (LSL : TSX-V)

Common Stock

$0.36

CAD

+0.01 (2.86%)

Last updated: 2026-08-13

Get LSL alerts:

LSL

LSL Pharma Group Inc.

Source:WealthAwesomeWealthAwesome
$0.04 (14.29%)
30 day period
$0.32$0.34$0.38Jul 2Jul 23Aug 13

Performance

1 Day

+2.86%

1 Week

+1.41%

1 Month

+10.77%

YTD

+2.86%

Key Statistics

Market Cap

$45.62M

52W High

$0.56

52W Low

$0.30

P/E Ratio

-

50 Day MA

$0.33

200 Day MA

$0.39

Beta

-0.49

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
8/13/2026$0.35$0.36$0.35$0.36$0.3614,000
8/12/2026$0.35$0.35$0.35$0.35$0.3513,000
8/11/2026$0.34$0.35$0.34$0.35$0.3523,000
8/10/2026$0.35$0.35$0.34$0.35$0.3517,000
8/7/2026$0.36$0.36$0.34$0.35$0.3591,008
8/6/2026$0.36$0.36$0.34$0.35$0.35102,000
8/5/2026$0.36$0.36$0.35$0.36$0.3613,500
8/4/2026$0.38$0.38$0.38$0.38$0.384,000
7/31/2026$0.36$0.38$0.35$0.38$0.3835,000
7/30/2026$0.36$0.36$0.35$0.36$0.3636,000

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on LSL's historical volatility

HistoricalForecast68%95%
C$0.17C$0.30C$0.42C$0.55C$0.68C$0.81TodayApr 7Jun 10Aug 13Sep 25Nov 8Dec 21

30-Day Vol

63.3%

Annualized

90-Day Vol

47.5%

Annualized

Trend (90d)

+5.9%

Annualized drift

90d Mean

C$0.37

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.36C$0.29C$0.45
60 trading daysC$0.37C$0.27C$0.50
90 trading daysC$0.37C$0.25C$0.54

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About LSL Pharma Group Inc.

LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. The company offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, and natural health products in liquid and semi-solid form for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada.

Financials

Revenue (TTM)
$34.42M
EBITDA
$-576,000
Profit Margin
-15.93%
ROE (TTM)
-22.35%
EPS (Diluted)
-0.04
Book Value
0.21

Classification

Sector
Health Care
Industry
Pharmaceuticals
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About LSL

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
DFSCDEFSEC Technologies Inc.$3.30+88.57%
GXGuardian Exploration Inc$0.16+52.38%
CCDCascadero Copper Corp$0.01+50.00%
NAQ-PNavigator Acquisition Corp$0.07+40.00%
PATPatriot One Technologies Inc$2.70+35.00%
ALTAlturas Minerals Corp$0.02+33.33%
CELLGrid Battery Metals Inc.$0.02+33.33%
GRIGalore Resources Inc$0.02+33.33%

LSL.V news timeline

1 article covering LSL.V, most recent first

Latest

Why LSL Pharma Group Inc. stock is plummeting today

Stocks

Advertisement